文献速递主动脉疾病

Castor单分支支架治疗2区主动脉弓病变及烟囱技术延伸至1/0区的早期结果

Early Outcomes of Castor Single-Branched Stent-Graft for Zone 2 Aortic Arch Pathologies and Exploratory Use in Proximal Extension to Zone 1/0 With Chimney Techniques.
PubMed 文献 · J Endovasc Ther · 2026-03-15

单中心回顾性研究纳入63例2区主动脉弓病变患者,采用Castor单分支支架,近端锚定区决定策略:标准2区37例、延伸1区20例(联合左颈总动脉烟囱)、延伸0区6例(联合头臂干烟囱及选择性左锁骨下动脉重建)。总体技术成功率96.8%,30天内无死亡、卒中、截瘫等,随访17.4个月,内漏率1.6%,分支闭塞率1.6%,烟囱支架均通畅。

要点

  • Castor单分支支架治疗2区主动脉弓病变技术成功率高,早期安全性好。
  • 联合烟囱技术可延伸至1区,并探索性用于0区,分支/烟囱通畅率高。
  • 内漏和分支闭塞发生率低,再干预率3.2%,全因死亡率1.6%。

核心结论

  • Castor单分支支架可有效重建2区主动脉弓病变,联合烟囱技术可延伸至1区并探索性用于0区。
  • 各策略均显示高技术成功率、良好安全性、高分支/烟囱通畅率和低并发症率。

研究设计与样本

  • 单中心回顾性研究,纳入2023年2月至2024年6月治疗的63例2区主动脉弓病变患者,平均年龄57.0±13.4岁,男性55例(87.3%)。
  • 近端锚定区决定治疗策略:标准2区37例(Castor分支置于左锁骨下动脉),延伸1区20例(Castor分支置于左锁骨下动脉+左颈总动脉烟囱),延伸0区6例(Castor分支置于左颈总动脉+头臂干烟囱+基于椎动脉优势选择性左锁骨下动脉重建)。

主要发现

  • 总体技术成功率96.8%(61/63)。
  • 术后30天内无死亡、卒中、截瘫、逆行A型主动脉夹层、内漏或上肢缺血发生。
  • 平均随访17.4±5.5个月,总体内漏率1.6%(1/63),为1例2区锚定患者3个月随访时发现左锁骨下动脉反流导致的II型内漏;无支架相关I/III型内漏。
  • 分支闭塞率1.6%(1/63),为1例1区锚定患者术后10个月Castor左锁骨下动脉分支闭塞;所有烟囱支架保持通畅。
  • 再干预率3.2%(2/63),包括1例2区锚定II型内漏和1例1区锚定左锁骨下动脉闭塞;全因死亡率1.6%(1/63),为1例1区锚定患者术后11个月死于非主动脉相关原因。

临床怎么用

  • 对于2区主动脉弓病变,Castor单分支支架是有效的血管内修复选择。
  • 联合烟囱技术可将Castor支架的应用延伸至1区,并可在高度选择的0区病例中探索性使用。
  • 该杂交策略为复杂弓部病变、高手术风险或无法定制支架的患者提供了微创血管内替代方案。

局限性

  • 单中心回顾性研究,样本量有限(63例),0区亚组仅6例,结论需更大样本验证。
  • 随访时间较短(平均17.4个月),长期结果未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the early-term outcomes of endovascular repair for zone 2 aortic arch pathologies using the Castor single-branched stent-graft, with adjunctive chimney technique employed when extending for proximal extension into zones 1 and 0. METHODS: A single-center retrospective study was conducted on 63 patients (mean age=57.0±13.4 years; 55 males, 87.3%) with zone 2 aortic pathologies treated between February 2023 and June 2024. Proximal landing zones determined treatment strategy: Standard zone 2 landing (n=37, Castor branch in left subclavian artery [LSA]); extended zone 1 landing (n=20, Castor branch in LSA+LCCA chimney); extended zone 0 landing (n=6, Castor branch in LCCA+innominate artery (IA) chimney+selective LSA revascularization based on vertebral artery dominance). Baseline characteristics, procedural data, and outcomes were analyzed to assess technical success, perioperative/follow-up complications, reinterventions, and branch patency. Outcomes were described separately for each landing zone cohort (zones 2, 1, and 0). RESULTS: The overall technical success was 96.8% (61/63). No mortality, stroke, paraplegia, retrograde type A aortic dissection/ (RTAAD), endoleak, or upper limb ischemia occurred within the 30-day postoperative period. During a mean follow-up of 17.4±5.5 months, the overall endoleak rate was 1.6% (1/63), comprising a single zone 2 landing type II endoleak (LSA backflow) detected at the 3-month follow-up. No graft-related type I/III endoleaks occurred. Branch occlusion occurred in 1.6% of cases (1/63), involving the Castor LSA branch in a zone 1 landing case at 10 months. All chimney stent-grafts maintained patency. Reinterventions (3.2%, 2/63) comprised: one zone 2 landing type II endoleak, and one zone 1 landing complications (LSA occlusion). All-cause mortality was 1.6% (1/63, occurring at 11 months postoperatively in a zone 1 landing patient due to non-aortic-related causes). CONCLUSIONS: The Castor single-branched stent-graft enabled effective zone 2 reconstruction. Combined with chimney technique, it facilitated treatment extension into zone 1 and exploratory applications in zone 0. The results for each strategy demonstrate high technical success, a favorable safety profile, high branch/chimney patency rates, and low-complication rates.Clinical ImpactThis study demonstrates that the Castor single-branched stent-graft is safe and effective in endovascular repair of zone 2 aortic arch pathologies. Combined with a chimney stent, its application can be successfully extended to zone 1 and exploratory zone 0 cases. This hybrid strategy provides a minimally invasive endovascular alternative for complex arch pathologies, particularly in patients at high surgical risk or ineligible for custom-made devices. This work contributes by providing the first detailed perioperative and follow-up data for this combined approach, including preliminary technical experience in highly selected zone 0 reconstructions, thereby enriching the evidence base for endovascular arch repair.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Zhang L, Xia D, Li Q, et al. Early Outcomes of Castor Single-Branched Stent-Graft for Zone 2 Aortic Arch Pathologies and Exploratory Use in Proximal Extension to Zone 1/0 With Chimney Techniques. J Endovasc Ther. 2026. PMID: 41833303. doi:10.1177/15266028261433405

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。